PHILADELPHIA, Sept. 5, 2017 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug ...

Dec. 17, 2003 — Esomeprazole is the most effective proton pump inhibitor (PPI) for gastric acid control, according to the results of a five-way crossover study published in the December issue of the ...

The US Food and Drug Administration (FDA) has approved the first generic version of AstraZeneca's proton pump inhibitor Nexium (esomeprazole magnesium delayed-release capsules) to treat ...

Proton-pump inhibitors (PPIs) are an effective treatment for acid-related conditions, but their efficacy for the treatment of patients with upper gastrointestinal symptoms resulting from nonsteroidal ...

Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES USP, 20 mg and 40 mg, a therapeutic equivalent generic version of NEXIUM® ...

Naproxen, esomeprazole (as magnesium trihydrate); 375mg/20mg, 500mg/20mg; del-rel tabs. The mechanism of action of the naproxen anion, like that of other NSAIDs, is not completely understood but may ...

Esomeprazole is a proton pump inhibitor that helps reduce the amount of gastric acid produced in the stomach. Image Credit: Sonis Photography / Shutterstock.com Esomeprazole achieves this by ...

According to the results of a phase III trial presented at the 2018 ASCO Annual Meeting, two simple over-the-counter medicines – high dose esomeprazole and low dose aspirin when taken regularly can ...

Amneal Pharmaceuticals LLC has launched generic esomeprazole strontium delayed-release capsules 49.3 mg. This new esomeprazole therapy is the generic equivalent of the recently launched brand ...

However, Novo Nordisk will remain blinded to the data until the trial reaches its formal completion date. Granules India Limited announced on Thursday that the US Food & Drug Administration (US FDA) ...

Esomeprazole is often used to relieve symptoms of gastroesophageal reflux during pregnancy. As there is currently no treatment option available to slow the progression of preeclampsia, clinicians ...

For gastric-acid reduction, the potassium-competitive acid blocker tegoprazan is associated with a lower risk of kidney function decline compared with the proton pump inhibitor esomeprazole. Use of a ...